FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Authority Hl7

73,988 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

R2: 0
R2B: 0
R3: 8,436
R4: 40,031
R4B: 11,108
R5: 13,752
R6: 661

By Realm

none: 4,083
au: 293
be: 440
ca: 440
ch: 1,529
cl: 519
cr: 88
cz: 869
de: 193
dk: 76
ee: 73
eu: 986
fi: 87
fr: 223
in: 29
it: 206
kr: 122
nl: 1,009
no: 26
nz: 49
pl: 245
pt: 22
se: 23
stt: 116
uk: 6
us: 19,368
uv: 42,832
other: 6

Start Prev Rows 41000 - 41200 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Usage #
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.184.json	Durvalumab Injectable	active	2024-11	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.185.json	Emapalumab Injectable	active	2024-11	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.186.json	Fludarabine Injectable	active	2021-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.187.json	Ipilimumab Injectable	active	2024-11	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.188.json	Nivolumab Injectable	active	2024-11	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.189.json	Pembrolizumab Injectable	active	2024-12	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.190.json	Polatuzumab Vedotin Injectable	active	2021-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.191.json	Pralatrexate Injectable	active	2021-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.192.json	Vincristine Injectable	active	2021-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.193.json	Methotrexate Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.194.json	Trastuzumab Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.195.json	Mitomycin Injectable	active	2021-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.196.json	Brentuximab Vedotin Injectable	active	2021-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.197.json	Doxorubicin Pegylated Liposomal Injectable	active	2024-11	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.198.json	Blinatumomab Injectable	active	2024-11	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.199.json	Trastuzumab Emtansine Injectable	active	2021-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.200.json	Gemtuzumab Ozogamicin Injectable	active	2021-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.201.json	Tagraxofusp Injectable	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.202.json	Axicabtagene Ciloleucel Injectable	active	2024-11	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.203.json	BRCA1	active	2023-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.204.json	BRCA2	active	2023-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.205.json	BRCA1 Testing	active	2023-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.207.json	Epithelial Ovarian Cancer	active	2024-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.208.json	Primary Peritoneal Cancer	active	2022-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.209.json	Fallopian Tube Cancer	active	2022-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.210.json	Multigene Panel	active	2023-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.211.json	BRCA1 and BRCA2	active	2023-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.212.json	BRCA1 and BRCA2 Testing	active	2023-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.213.json	BRAF V600	active	2022-01	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.214.json	BRAF V600 Testing	active	2023-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.215.json	Colorectal Cancer	active	2024-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.216.json	BRAF V600 Mutation Status	active	2022-01	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.217.json	Cancer Stage I	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.218.json	Head and Neck Cancer	active	2022-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.219.json	Malignant Melanoma of Skin	active	2022-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.220.json	Brain Cancer	active	2022-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.221.json	Waldenstrom Macroglobulinemia	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.222.json	High Emetic Risk Intravenous Antineoplastic Agent	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.223.json	Moderate Emetic Risk Intravenous Antineoplastic Agent	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.224.json	Docetaxel Injectable	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.225.json	Cyclophosphamide Injectable	active	2022-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.226.json	LAG 3 Inhibitor	active	2024-11	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.233.json	Chemotherapy Administration	active	2024-01	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.240.json	Pathological N Stage N3c	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.241.json	Audio Visual Telehealth Encounter	active	2025-01	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.242.json	Moderate or High Emetic Risk Oral Antineoplastic Agent	active	2025-04	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.243.json	Minimal to Low Emetic Risk Oral Antineoplastic Agent	active	2025-04	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.244.json	Copanlisib Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.245.json	Isatuximab Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.246.json	Loncastuximab tesirine Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.247.json	Margetuximab Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.248.json	Mirvetuximab soravtansine Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.249.json	Tafasitamab Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.250.json	Teclistamab Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.251.json	Tisotumab Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.252.json	Asparaginase Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.254.json	Belantamab Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.255.json	Dostarlimab Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.256.json	Mosunetuzumab Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.257.json	Tremelimumab Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.258.json	Indication for Dexamethasone	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.260.json	Indication for Olanzapine	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.261.json	Indication for Dexamethasone	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.263.json	Indication for Olanzapine	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.264.json	Prednisone	active	2025-04	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.265.json	As Needed PRN	active	2025-04	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.266.json	Amivantamab Injectable	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.200.json	Doxorubicin	active	2020-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.201.json	Epirubicin	active	2020-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.202.json	Capecitabine	active	2023-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.203.json	Cyclophosphamide	active	2020-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.204.json	Injectable Fluorouracil	active	2020-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.205.json	Methotrexate	active	2020-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.206.json	Trastuzumab and Biosimilars	active	2020-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.207.json	HER2 Presence in Tissue	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.208.json	Carboplatin	active	2020-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.209.json	Depression Screening for Adult	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.210.json	Long Acting Opioids	active	2020-10	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.211.json	High Fiber Supplement or Diet Education	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.212.json	Dexamethasone	active	2021-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.213.json	Olanzapine	active	2021-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.214.json	Pancreatic Cancer	active	2020-10	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.215.json	Audio Visual Telehealth Encounter	active	2025-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.216.json	Telephone Encounter	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.217.json	Telehealth Emergency Department or Initial Inpatient	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.218.json	Dyspnea Assessment	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.219.json	Nausea or Vomiting Assessment	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.220.json	Karnofsky Performance Status	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.221.json	Referral to Hospice Care	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.222.json	Referral to Palliative Care	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.223.json	Palliative Care	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.224.json	Enrollment in Hospice Care	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.225.json	Advance Directive Including Durable Power of Attorney or Instructional	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.229.json	Minimal Emetic Risk Intravenous Antineoplastic Agent	active	2025-04	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.232.json	Epithelial Ovarian Cancer	active	2023-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.233.json	Primary Peritoneal Cancer	active	2022-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.235.json	BRCA2 Testing	active	2023-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.236.json	Multigene Panel	active	2023-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.237.json	BRCA1 Testing	active	2023-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.238.json	First Line Drug Therapy for Metastatic Colorectal Cancer	active	2022-01	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.239.json	BRAF V600 Testing	active	2022-01	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.240.json	Cancer Stage 4	active	2022-01	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.241.json	Cancer Stage M1	active	2024-12	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.242.json	High Emetic Risk Intravenous Antineoplastic Agent	active	2022-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.243.json	Moderate Emetic Risk Intravenous Antineoplastic Agent	active	2024-10	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.245.json	Antiemetic Agent	active	2025-04	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.247.json	Indication for Dexamethasone	active	2025-04	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.1444.5.249.json	Indication for Olanzapine	active	2025-04	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.2074.1.1.3.json	Race Category Excluding Nulls	active	2024-06	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.1002.77.json	Codeine	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.1004.13.json	Dihydrocodeine	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.1004.14.json	Nalbuphine	active	2020-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4009.json	Malignant Intracranial Neoplasm	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4010.json	Malignant Intracranial Neoplasm	active	2023-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4015.json	STEMI	active	2022-02	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4016.json	STEMI	active	2019-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4017.json	STEMI	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4019.json	Fibrinolytic Therapy	active	2023-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4023.json	Cerebral Vascular Lesion	active	2025-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4024.json	Cerebral Vascular Lesion	active	2025-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4025.json	Cerebral Vascular Lesion	active	2019-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4026.json	Closed Head and Facial Trauma	active	2019-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4028.json	Aortic Dissection or Ruptured Aortic Aneurysm	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4029.json	Acute Peptic Ulcer	active	2023-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4030.json	Acute Peptic Ulcer	active	2023-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4031.json	Acute Peptic Ulcer	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4032.json	Dementia and Related Intracranial Pathologies	active	2025-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4033.json	Dementia and Related Intracranial Pathologies	active	2025-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4034.json	Active Bleeding or Bleeding Diathesis, Excluding Menses	active	2025-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4035.json	Active Bleeding or Bleeding Diathesis, Excluding Menses	active	2022-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4036.json	Active Bleeding or Bleeding Diathesis, Excluding Menses	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4043.json	Dementia and Related Intracranial Pathologies	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4044.json	Aortic Dissection or Ruptured Aortic Aneurysm	active	2022-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4045.json	Oral Anticoagulant Medications	active	2023-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4046.json	Cardiopulmonary Emergency	active	2025-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4047.json	Cardiopulmonary Emergency	active	2025-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4048.json	Cardiopulmonary Emergency	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4049.json	Mechanical Circulatory Assist Device	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4050.json	Mechanical Circulatory Assist Device	active	2025-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4052.json	Mechanical Circulatory Assist Device	active	2025-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4053.json	Pregnant State	active	2022-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4054.json	Pregnant State	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4055.json	Pregnant State	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3157.4056.json	Major Surgical Procedure	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3566.2.1005.json	Chronic Stable Angina	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3566.2.1006.json	Chronic Stable Angina	active	2023-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.3566.3.1002.json	Chronic Stable Angina	active	2021-04	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1001.json	Hospice Encounter	active	2021-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1002.json	Hospice Encounter	active	2023-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1003.json	Hospice Encounter	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1004.json	Nutrition Services	active	2021-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1005.json	Nutrition Services	active	2021-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1006.json	Nutrition Services	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1007.json	Hospice Care Ambulatory	active	2021-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1008.json	Hospice Care Ambulatory	active	2021-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1005.json	Office Visit	active	2023-11	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1020.json	Initial Hospital Inpatient Visit	active	2017-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1030.json	Discharge Services Hospital Inpatient Same Day Discharge	active	2017-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1035.json	Discharge Services Hospital Inpatient	active	2017-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1040.json	Outpatient Consultation	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1050.json	Emergency Department Evaluation and Management Visit	active	2017-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1060.json	Nursing Facility Visit	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1065.json	Discharge Services Nursing Facility	active	2017-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1080.json	Home Healthcare Services	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1110.json	Preventive Care, Initial Office Visit, 0 to 17	active	2017-05	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1115.json	Preventive Care Services Initial Office Visit, 18 and Up	active	2017-05	us	6
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1120.json	Preventive Care, Established Office Visit, 0 to 17	active	2017-05	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1125.json	Preventive Care Services Established Office Visit, 18 and Up	active	2017-05	us	6
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1130.json	Preventive Care Services Individual Counseling	active	2017-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1135.json	Preventive Care Services Group Counseling	active	2017-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1215.json	Referral	active	2023-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1216.json	Face-to-Face Interaction	active	2017-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1221.json	Behavioral Health Follow up Visit	active	2020-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1222.json	Psychotherapy and Pharmacologic Management	active	2017-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1228.json	Detoxification Visit	active	2021-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1232.json	Audiology Visit	active	2017-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1233.json	Medical Disability Exam	active	2019-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1260.json	Telephone Visits	active	2025-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1261.json	Nursing Facility Visit	active	2018-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1262.json	Care Services in Long Term Residential Facility	active	2018-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1264.json	Office Visit	active	2025-01	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1265.json	Home Healthcare Services	active	2021-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1266.json	Outpatient Consultation	active	2020-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1276.json	Frailty Encounter	active	2019-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1277.json	Outpatient Encounter	active	2025-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1278.json	Outpatient Encounter	active	2025-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1279.json	Frailty Encounter	active	2019-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1284.json	Outpatient Encounter	active	2023-11	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1285.json	Palliative Encounter	active	2025-01	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1286.json	Palliative Encounter	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.11.1287.json	Telephone Visits	active	2021-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.12.1001.json	Office Visit	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.12.1004.json	Initial Hospital Inpatient Visit	active	2017-05	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.12.1006.json	Discharge Services Hospital Inpatient Same Day Discharge	active	2017-05	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.12.1007.json	Discharge Services Hospital Inpatient	active	2017-05	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.12.1008.json	Outpatient Consultation	active	2024-01	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.12.1010.json	Emergency Department Evaluation and Management Visit	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.12.1012.json	Nursing Facility Visit	active	2024-01	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.12.1013.json	Discharge Services Nursing Facility	active	2017-05	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.101.12.1014.json	Care Services in Long Term Residential Facility	active	2024-02	us